Cant decide what I think. I think its ok
positive Thoughts:
-New board member from SIMEC = great
-Money to actually advance projects attached to reaching milestones = great
-fully funded two projects to DFS stage (CAP is still chasing funding for DFS) = great
-SIMEC willing to invest $100m in a company valued at $33m = SIMEC confident in projects = great
-Strong connection made with SIMEC/GFG = great
-Publicity for HAV due to connection with Gupta= Great
-For years I've been reading about HAV's potential, based off huge resources, but nothing has really come of it. This deal thrusts HAV into the spotlight and funds major works to advance projects.= great
-On my reading HAV can raise funds at market prices if the share price appreciates. SIMEC can participate if they want.= may not dilute as much as first thought if share price appreciates. see quote below.= good
-Even if dilution is fully to 50% (or 75% with the 100m spend) with a DFS completed on 3.5bill tonne JORC resource, and SIMEC advancing their new steel plant, HAV's value would have to sky rocket.= great
-They've left the door open for any other companies that want to offer a better deal before everything is signed.= great
-The alternative is to scratch around with no money for the next year or two hoping to find a better deal= not good.
-Specific comments by Gupta at the press release regarding copper as part of their plan=great.
Negatives
Basically mass dilution upwards of 50-75% depending on how much of it HAV accesses=not good
No increase on price that SIMEC has to pay for shares as projects advance=not good.
The big question:
Is the positive advancements in projects going to be worth the amount of dilution in share value?
Justhavinago
- Forums
- ASX - By Stock
- HAV
- Ann: Havilah Secures Funding of up to $100M from GFG Alliance
Ann: Havilah Secures Funding of up to $100M from GFG Alliance, page-41
-
-
- There are more pages in this discussion • 164 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HAV (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.5¢ |
Change
0.010(4.26%) |
Mkt cap ! $77.57M |
Open | High | Low | Value | Volume |
23.5¢ | 24.5¢ | 23.5¢ | $70.82K | 294.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 58681 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 137807 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 58681 | 0.240 |
2 | 51997 | 0.230 |
1 | 3886 | 0.220 |
2 | 37636 | 0.210 |
2 | 222456 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 137807 | 4 |
0.250 | 113134 | 4 |
0.260 | 79889 | 4 |
0.270 | 50000 | 1 |
0.275 | 37500 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
HAV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online